Ischemia-free liver transplantation. Is this the right answer to overpass organ shortage and post-liver transplant complications?
Davide Ghinolfi, Wayel Jassem, Paulo N. Martins
The Lancet Regional Health. Western Pacific · 2021
doi:10.1016/j.lanwpc.2021.100263 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Liver transplantation (LT) results dramatically improved over the past years; nevertheless, the number of patients awaiting LT far exceeds the available grafts and waiting list mortality remains high. The use of so-called “extended criteria” donors (ECD) is proposed to improve the availability of donor allografts and reduce waiting list mortality [1]. Most ECD livers share the common denominator of being more vulnerable to ischemia-reperfusion injury (IRI) in comparison to standard grafts, hence carrying an increased risk of post-LT early allograft dysfunction (EAD), primary non-function and ischemic cholangiopathy [1, 2].
Abstract licence: CC BY-NC-ND
References10
10 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.